|
TBC1D22B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.889900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.189800E-04 |
| Normal-vs-Stage2 |
9.681000E-01 |
| Normal-vs-Stage3 |
7.796600E-01 |
| Normal-vs-Stage4 |
8.134400E-01 |
| Stage1-vs-Stage2 |
3.007900E-02 |
| Stage1-vs-Stage3 |
4.081000E-03 |
| Stage1-vs-Stage4 |
1.158180E-03 |
| Stage2-vs-Stage3 |
8.912200E-01 |
| Stage2-vs-Stage4 |
8.463600E-01 |
| Stage3-vs-Stage4 |
6.343000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.071820E-01 |
| Normal-vs-AfricanAmerican |
4.659800E-02 |
| Normal-vs-Asian |
6.4810999999998E-05 |
| Caucasian-vs-AfricanAmerican |
2.647800E-01 |
| Caucasian-vs-Asian |
1.383910E-02 |
| AfricanAmerican-vs-Asian |
4.829900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.755800E-01 |
| Normal-vs-Female |
9.30649999952848E-07 |
| Male-vs-Female |
1.39750000460737E-09 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.356200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.163500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.569000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.853600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.271560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.325400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.593000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.766200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.162800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.692000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.441000E-03 |
| Normal-vs-Grade 2 |
2.059700E-03 |
| Normal-vs-Grade 3 |
1.745750E-01 |
| Normal-vs-Grade 4 |
8.735900E-02 |
| Grade 1-vs-Grade 2 |
4.991800E-02 |
| Grade 1-vs-Grade 3 |
5.377600E-03 |
| Grade 1-vs-Grade 4 |
5.98149999999631E-05 |
| Grade 2-vs-Grade 3 |
5.756200E-02 |
| Grade 2-vs-Grade 4 |
6.1302999999957E-05 |
| Grade 3-vs-Grade 4 |
5.015000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.92799999485661E-08 |
| Normal-vs-ccB subtype |
1.511430E-01 |
| ccA subtype-vs-ccB subtype |
5.30064880877035E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.537760E-02 |
| Normal-vs-N1 |
3.792600E-01 |
| N0-vs-N1 |
1.143010E-01 |
|
|
